Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease (COMPASS)

This study is ongoing, but not recruiting participants.

Sponsor:

Collaborators:

Hamilton Health Sciences Corporation, Population Health Research Institute

Janssen Research & Development, LLC

Information provided by (Responsible Party):

Bayer

ClinicalTrials.gov Identifier:

NCT01776424

First received: January 24, 2013

Last updated: April 21, 2017

Last verified: April 2017

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	March 31, 2018
Estimated Primary Completion Date:	May 15, 2017 (Final data collection date for primary outcome measure)